Health‐related quality of life · people with chronic liver diseases
1 finding from 1 review
Non‐serious adverse events · people with chronic liver diseases
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Failure of sustained virological response · people with chronic liver diseases
It is very uncertain whether vitamin D changes failure of sustained virological response compared with placebo or no intervention (very low certainty).
1 finding from 1 review
All‐cause mortality at 5 years · people with resectable cholangiocarcinoma
It is very uncertain whether adjuvant chemotherapy changes all‐cause mortality at 5 years compared with no chemotherapy (very low certainty).
1 finding from 1 review
Serious adverse events · people with resectable cholangiocarcinoma
It is very uncertain whether adjuvant chemotherapy changes serious adverse events compared with no chemotherapy (very low certainty).
1 finding from 1 review
Health‐related quality of life · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cancer‐related mortality at maximal · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to recurrence · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐serious adverse events · people with resectable cholangiocarcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality: 1‐year overall survival · people with resectable cholangiocarcinoma
It is very uncertain whether adjuvant S‐1 changes all‐cause mortality: 1‐year overall survival compared with gemcitabine (very low certainty).
1 finding from 1 review
All‐cause mortality: 2‐year overall survival · people with resectable cholangiocarcinoma
It is very uncertain whether adjuvant S‐1 changes all‐cause mortality: 2‐year overall survival compared with gemcitabine (very low certainty).
1 finding from 1 review
Serious adverse events · people with resectable cholangiocarcinoma
1 finding from 1 review
Intervention not reported
Interventions · people with liver cirrhosis and oesophageal varices with no history of bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Portocaval shunt(No direct RCT) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes portocaval shunt(No direct RCT) (very low certainty).
1 finding from 1 review
HR 0.51 [0.06, 2.92]
Studies not reported
Very low
Intervention not reported
Variceal band ligation(5 RCTs, 372 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes variceal band ligation(5 RCTs, 372 participants) (very low certainty).
1 finding from 1 review
OR 0.75 [0.02, 23.24]
Studies not reported
Very low
Intervention not reported
Sclerotherapy(1 RCT, 85 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes sclerotherapy(1 RCT, 85 participants) (very low certainty).
1 finding from 1 review
OR 0.55 [0, 272.05]
Studies not reported
Very low
Intervention not reported
Variceal band ligation(1 RCT, 168 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
No active intervention(2 RCTs, 256 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes no active intervention(2 RCTs, 256 participants) (very low certainty).
1 finding from 1 review
OR 0.28 [0.02, 2.91]
Studies not reported
Very low
Intervention not reported
Variceal band ligation(7 RCTs, 728 participants) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes variceal band ligation(7 RCTs, 728 participants) (very low certainty).
1 finding from 1 review
OR 1.6 [0.54, 5.15]
Studies not reported
Very low
Intervention not reported
Sclerotherapy(No direct RCT) · people with liver cirrhosis and oesophageal varices with no history of bleeding
It is very uncertain whether the intervention changes sclerotherapy(No direct RCT) (very low certainty).
1 finding from 1 review
OR 1.19 [0.02, 80.24]
Studies not reported
Very low